Procurement Summary
Country : Serbia
Summary : Medicines Outside the List of Medicines
Deadline : 27 Jun 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 102654592
Document Ref. No. : A309/2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Acetylcysteine, Burosumab, Dantrolene, Idarucizumab, Methoxalen, Somatostatin, Tetracosactide, Labetalol, Human plasma proteins blood group A, B, AB, O
Procedure status :- Ordering party UNIVERSITY CLINICAL CENTER OF SERBIA Ordering place RS110 - Belgrade region, BELGRADE
Documents
Tender Notice